Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14527-14536
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14527
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14527
Regimen | Standard dose PPI bid (esomeprazole is qid), clarithromycin 500 mg bid, amoxicillin 1000 mg bid for 10–14 d | Standard dose PPI bid, clarithromycin 500 mg bid metronidazole 500 mg bid for 10–14 d | Bismuth subsalicylate 525 mg po qid metronidazole 250 mg po qid, tetracycline 500 mg po qid, ranitidine 150 mg po bid or standard dose PPI qid to bid for 10–14 d | PPI + amoxicillin 1 g bid 5 d followed by PPI, clarithromycin 500 mg, tinidazole 500 mg bid for 5 d |
Note | Consider in nonpenicillin allergic patients who have not previously received a macrolide | Consider in penicillin allergic patients who have not previously received a macrolide or are unable to tolerate bismuth quadruple therapy | Consider in penicillin allergic patients | Requires validation in North America |
-
Citation: Nagaraja V, Eslick GD. Evidence-based assessment of proton-pump inhibitors in
Helicobacter pylori eradication: A systematic review. World J Gastroenterol 2014; 20(40): 14527-14536 - URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14527.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14527